Perioperative Lenvatinib With Pembrolizumab in Patients With Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma

NCT04393350 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Kidney Cancer
Stage III Renal Cell Cancer AJCC v8
Stage IV Renal Cell Cancer AJCC v8

Interventions

DRUG: Lenvatinib
DRUG: Lenvatinib Mesylate
BIOLOGICAL: Pembrolizumab
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration

Sponsor

Emory University

Collaborators

[object Object]
[object Object]